QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 20 March 2007
doi: 10.1242/jcs.000018

This Article Figures Only Full Text Full Text (PDF) Supplementary Material All Versions of this Article: jcs.000018v1 120/8/1393    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nazarenko, I. Articles by Sers, C. Search for Related Content PubMed PubMed Citation Articles by Nazarenko, I. Articles by Sers, C. Social Bookmarking                         What's this?

Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinoma cells

Irina Nazarenko^*, Reinhold Schäfer and Christine Sers

Molecular Tumor Pathology, Institute of Pathology, University Medicine Charité Berlin, Schumannstrasse 20/21, 10117 Berlin, Germany

Author for correspondence (e-mail: christine.sers{at}charite.de)

Accepted 29 January 2007

HRSL3 (also known as H-REV107-1) belongs to a class II tumor suppressor gene family and is downregulated in several human tumors including ovarian carcinomas. To unravel the mechanism of HRSL3 tumor suppressor action, we performed a yeast two-hybrid screen and identified the -isoform of the regulatory subunit A of protein phosphatase 2A (PR65) as a new interaction partner of HRSL3. Interaction between HRSL3 and PR65 was confirmed in vitro and by co-immunoprecipitation in mammalian cells. We demonstrate that HRSL3 binds to the endogenous PR65, thereby partially sequestering the catalytic subunit PR36 from the PR65 protein complex, and inhibiting PP2A catalytic activity. Furthermore, binding of HRSL3 to PR65 induces apoptosis in ovarian carcinoma cells in a caspase-dependent manner. Using several mutant HRSL3 constructs, we identified the N-terminal proline-rich region within the HRSL3 protein as the domain that is relevant for both binding of PR65 and induction of programmed cell death. This suggests that the negative impact of HRSL3 onto PP2A activity is important for the HRSL3 pro-apoptotic function and indicates a role of PP2A in survival of human ovarian carcinomas. The analysis of distinct PP2A target molecules revealed PKC as being involved in HRSL3 action. These data implicate HRSL3 as a signaling regulatory molecule, which is functionally involved in the oncogenic network mediating growth and survival of ovarian cancer cells.

Key words: Tumor suppressor, HRSL3, PP2A, Apoptosis

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

Related articles in JCS:

REVving up cancer

JCS 2007 120: 801. [Full Text]  

This article has been cited by other articles:

				T. Uyama, J. Morishita, X.-H. Jin, Y. Okamoto, K. Tsuboi, and N. Ueda The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type J. Lipid Res., April 1, 2009; 50(4): 685 - 693. [Abstract] [Full Text] [PDF]

				R. E. Duncan, E. Sarkadi-Nagy, K. Jaworski, M. Ahmadian, and H. S. Sul Identification and Functional Characterization of Adipose-specific Phospholipase A2 (AdPLA) J. Biol. Chem., September 12, 2008; 283(37): 25428 - 25436. [Abstract] [Full Text] [PDF]